Dyno Nobel (ASX:DNL) has completed the sale of its fertilisers distribution business to Ridley Corporation, receiving upfront proceeds of $381 million, with additional purchase price adjustments ...

The economics of crypto mining have shifted due to rising electricity costs and declining profitability from reduced Bitcoin (CRYPTO:BTC) mining rewards. Many mining firms are now moving into AI data ...

หน่วยงานนี้ยังควบคุมบริษัทสินทรัพย์ดิจิทัล เช่น Coinbase, Circle และ Paxos ภายใต้กรอบการทำ BitLicense ของรัฐนิวยอร์ก การนำของ Harris วางตำแหน่ง ...

Amplia Therapeutics (ASX:ATX) has received notice from the US Patent and Trademark Office allowing a key patent for its lead FAK inhibitor, narmafotinib, with formal grant expected in the coming ...

PolyNovo (ASX:PNV) has confirmed its NovoSorb products, including the Biodegradable Temporising Matrix and NovoSorb MTX, will not be subject to the 100% tariff on pharmaceutical products announced by ...

Alcoa Corporation (ASX:AAI) will permanently close its Kwinana alumina refinery in Western Australia, ending more than six decades of operations at the site. The decision follows the curtailment of ...

SeaStar Medical (NASDAQ:ICU) has announced encouraging preliminary outcomes from its SAVE Surveillance Registry evaluating the QUELIMMUNE therapy for treating pediatric Acute Kidney Injury (AKI), ...

Johnson & Johnson (NYSE:JNJ) today announced a significant expansion for its drug TREMFYA® (guselkumab), which has received approval from the U.S. Food and Drug Administration (FDA) to treat children ...

Resonetics (NYSE:CG) has announced a strategic acquisition of Eden Holdings, which includes Eden Manufacturing and Eden Tool, to significantly expand its precision manufacturing and tooling ...

Medicus Pharma (NASDAQ:MDCX) has announced a major regulatory and strategic advance, receiving positive feedback from the U.S. Food and Drug Administration (FDA) regarding the development of its novel ...

Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) has announced plans to initiate a Phase 2 clinical trial in 2026 for its investigational drug, TNX-2900, a proprietary intranasal potentiated oxytocin ...

Vyome Holdings (NASDAQ:HIND), a clinical-stage healthcare holding company, today announced the acquisition of substantially all assets from Oculo, an innovative AI startup originating from the ...